CClinicalTrials.gg
CompletedNCT07131072Updated Aug 24, 2025

Assessment of Diaphragmatic Mobility in Dyspneic Patients With Different Types of Interstitial Lung Diseases

An observational study in Diaphragm Issues, sponsored by Ain Shams University. Completed at 1 site in Egypt. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-08-24.

Sponsored by Ain Shams University · Observational

Study type
Observational
Model
Other
Time perspective
Prospective
Enrollment
100
Ages
18 Years and older
Sex
All
01

Study summary

dyspnea and impaired exercise capacity in IPF patients can be related, at least in part, to respiratory muscle dysfunction, in particular to diaphragm functionality. Both B-mode and M-mode ultrasound techniques have been employed to assess diaphragm excursion, which measures the distance that the diaphragm is able to move during the respiratory cycle.

recent study using lung ultrasound in assessment of diaphragmatic mobility in IPF patients and found that Diaphragmatic mobility is lower in IPF patients than in healthy controls, especially during deep inspiration. The correlation between reduced FVC and diaphragmatic excursion values in IPF patients can be of interest, since it could represent an index of functional respiratory affection performed by chest ultrasound

Read the detailed description

Interstitial lung diseases are known to be associated with limitations in daily activities and impaired quality of life. One of the most troublesome burdens for ILD patients is dyspnea during exercise, which extends to the resting state as the disease advances. The causes of dyspnea are suggested to be a progressive decline in total lung capacity (TLC) and vital capacity, along with impairment of diffusion capacity and subsequent development of (primarily hypoxic) respiratory failure along with respiratory muscle dysfunction.

Studies have supported the advantage of ultrasonography in the assessment of diaphragmatic mobility by two-dimensional (BD) or M-mode. Others reported the investigation methods, the criteria for normal and pathological diaphragmatic function, and the perspectives of development in adult patients.

02

Conditions studied

  • Diaphragm Issues
03

In context

Lead sponsor

Ain Shams University is the lead sponsor of 1,876 studies on the registry; 423 are open to participants now.

Of its 32 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients presented to Ain Shams University Hospital's chest outpatient clinic by ILD due to any cause with age more than 18 years

Inclusion criteria

  • patients presented to Ain Shams University Hospital outpatient clinic by ILD due to any cause

Exclusion criteria

Exclusion Criteria:

  • Pregnant females
  • Patients with end stage organ failure e.g.: Renal failure, liver cell failure
  • Patients with malignancy elsewhere.
  • The patients who refuse to be entitled in the study.
05

Study design

Observational model
Other
Time perspective
Prospective
Enrollment
100 participants (actual)
Patient registry
No

Groups and cohorts

  • collagen related interstitial lung disease

    Other: daiphragm mobility by ultrsound · Other: spirometry ,DLCo

  • idiopathic type (IPF)

    Other: daiphragm mobility by ultrsound · Other: spirometry ,DLCo

  • OTHERS(occupational,sarcoid,...)

    Other: daiphragm mobility by ultrsound · Other: spirometry ,DLCo

Interventions

  • Otherdaiphragm mobility by ultrsound

    fibrosis score, alveolitis score by CT Chest

    Also known as: warricks score

  • Otherspirometry ,DLCo

    FEV1, FVC, FEV1/FVC, DLCo

06

What researchers measure

Primary outcomes

  1. diaphragm mobility assessment in different types of interstitial lung diseases

    measurement of diaphragmatic excursion in cm in different types of interstitial lung diseases

    Time frame: 1 year

Secondary outcomes

  1. Correlation between diaphragmatic mobility and functional assessment in different ILD types

    find the correlation between excursion measurements and spirometry indices, DLCO and CT fibrosis score

    Time frame: 1 year

07

Study locations

1 site
  • Ain Shams university
    Cairo, Egypt
08

References and documents

Individual participant data

Plan to share: No — no IPD will be shared

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 24, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07131072
Lead sponsor
Ain Shams University
Responsible party
hieba gamal ezz-elragal awad (Assistant professor, Ain Shams University) — Principal investigator
First posted
Aug 20, 2025
Start date
Feb 1, 2021
Primary completion
Sep 1, 2022
Completion
Jun 1, 2025
Last update
Aug 24, 2025

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion